Back to Search Start Over

Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study.

Authors :
Frahm, Niklas
Ellenberger, David
Fneish, Firas
Christoph, Kleinschnitz
Warnke, Clemens
Zettl, Uwe K.
Paul, Friedemann
Rauser, Benedict
Stahmann, Alexander
Vogelmann, Vroni
Flachenecker, Peter
Source :
Multiple Sclerosis & Related Disorders; Nov2021, Vol. 56, pN.PAG-N.PAG, 1p
Publication Year :
2021

Abstract

• Of 1,513 SPMS patients, 30.9% had an active and 69.1% had an inactive MS course. • Further 2,750 SPMS patients could not be classified due to missing MRI data. • Low MRI frequencies are common in people of high age and of long disease duration. • Annual or at least regular MRI assessments are not done for a significant subgroup. • Active and inactive SPMS patients were similar in symptomatology, care and therapy. The tailored immunomodulatory treatment strategy for secondary progressive multiple sclerosis (SPMS) depends on disease activity. To assess the real-world situation in monitoring disease activity in SPMS patients and to identify associations of resulting subgroups with demographics, symptomatology, and therapy This study included 4,263 SPMS patients from the German MS register (GMSR). For the classification into 'active' and 'inactive' according to relapse activity and MRI findings during the year prior to the latest clinical visit, we used the following definitions: active - gadolinium enhancing (Gd+)/new T2 lesions or ≥1 relapse, inactive - neither Gd+/new T2 lesions nor relapses. The active, inactive, and unclassifiable patients were compared in terms of clinical data, socio-demographics, symptomatology, healthcare, and DMT. Classification was possible for 1,513 (35.5%) SPMS patients, with 467 classified as active and 1,046 as inactive. For the classification, MRI data was available for 33.2% of the 4,263 patients. Higher MRI frequencies were observed for younger patients (OR 1.22 [1.12,1.33] per 10 years) with short disease duration (OR 1.19 [1.09, 1.30] per 10 years) (p < 0.001). MRI coverage was low, especially in elderly SPMS patients. Roughly one third of the SPMS patients presented markers of disease activity in the last year. Overall, the clinical differences (concerning symptomatology and care) between patients with active and inactive SPMS were small. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22110348
Volume :
56
Database :
Supplemental Index
Journal :
Multiple Sclerosis & Related Disorders
Publication Type :
Academic Journal
Accession number :
154084886
Full Text :
https://doi.org/10.1016/j.msard.2021.103281